Technology News and Research

RSS

Bowel Research UK partners with Symplectic Grant Tracker to advance life-changing research

Digital Science, a technology company serving stakeholders across the research ecosystem, is pleased to announce that Bowel Research UK (BRUK) has chosen Symplectic Grant Tracker from Digital Science's suite of flagship products to advance its aims of funding life-changing research into bowel cancer and other bowel diseases.

6 Jul 2023

Researchers identify an enzyme that plays a critical role in the late stages of HIV replication

Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines have identified an enzyme that plays a critical role in the late stages of HIV replication.

6 Jul 2023

COST Connect: A platform for collaboration and progress in cancer research

Beating cancer is a major challenge for research and innovation in the coming years. By 2030, it is estimated that over 1.5 million people in the EU will succumb to cancer.

6 Jul 2023

Swarm learning shows promise in cancer research

The DECADE research project is the first to use swarm learning in cancer research. The German Cancer Aid is funding the joint project of several university hospitals with around 1.5 million euros.

6 Jul 2023

Scientists develop breakthrough approach to create artificial allosteric sites in protein complexes

According to a recently published research paper by a team of scientists, a groundbreaking approach has been developed to create artificial allosteric sites (where by binding an effector molecule, activity at the distal active site is regulated) in protein complexes.

6 Jul 2023

Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced updates to its flagship platform, Cyto-Mine®, enabling it to be compliant with current Good Manufacturing Practice (cGMP) regulations enforced by the US FDA.

From Fluidic Sciences and Sphere Bio 6 Jul 2023

New therapy to mitigate fragile X syndrome may be on the horizon

An antisense therapy developed by Joel D. Richter, PhD, Sneha Shah, PhD, and Jonathan K. Watts, PhD, at UMass Chan Medical School and Elizabeth Berry-Kravis, MD, PhD, at RUSH University Medical Center, restores production of the protein FMRP in cell samples taken from patients with fragile X syndrome.

5 Jul 2023

Combination of techniques reveals molecular changes in osteoarthritis

Osteoarthritis is the most common degenerative joint disease, affecting 22% of adults over 40 globally. Although the condition has been extensively studied through a medical perspective, the molecular changes associated with osteoarthritis remain unclear.

5 Jul 2023

Gum disease and tooth loss linked to brain shrinkage

Taking good care of your teeth may be linked to better brain health, according to a study published in the July 5, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

5 Jul 2023

New CRISPR-based system could eliminate malaria-carrying mosquitoes

Malaria remains one of the world's deadliest diseases. Each year malaria infections result in hundreds of thousands of deaths, with the majority of fatalities occurring in children under five.

5 Jul 2023

TBI-associated depression may be a distinct disorder

A new study led by Shan Siddiqi, MD, from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, suggests that depression after traumatic brain injury (TBI) could be a clinically distinct disorder rather than traditional major depressive disorder, with implications for patient treatment.

5 Jul 2023

Major agreement moves ground-breaking new cancer treatments a step closer to patients

Ground-breaking new cancer treatments have moved a step closer with the signing of a major agreement between the government and BioNTech SE.

5 Jul 2023

Less than half of approved new drugs add substantial therapeutic value over existing treatments

New drugs are often used not only for one disease (first approved indication) but also for other diseases (supplemental indications).

5 Jul 2023

Researchers develop dissolving cardiac device to monitor and treat heart disease

Nearly 700,000 people in the United States die from heart disease every year, and one-third of those deaths result from complications in the first weeks or months following a traumatic heart-related event.

5 Jul 2023

Using a vaccine to boost the response of engineered T cells

Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn't worked as well for solid tumors.

5 Jul 2023

Arima Genomics continues momentum toward clinic with formation of clinical advisory board

Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights to improve human health and drive discovery in the life sciences, today announced the formation of a clinical advisory board to help the company advance its 3D genomics technologies into the clinical oncology and biopharmaceutical markets.

From Arima Genomics, Inc. 5 Jul 2023

Mount Sinai launches first-of-its-kind center for ophthalmic AI

The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.

5 Jul 2023

Serious monkey business: Chimpanzee heart check via digital camera

A world-first experiment to measure chimpanzee heart rates via a digital camera could help curb cardiovascular disease in great apes in captivity and provide valuable insights into how their brain develops from an early age.

5 Jul 2023

Next step in Sartorius partnership finalized: Several subsales and distribution agreements as well as R&D project agreements have been signed

During May and June 2023 several sub-sales and distribution agreements were signed between Sartorius and BICO companies CELLINK, Advanced BioMatrix (ABM) and Dispendix.

From BICO 5 Jul 2023

AANS, CNS urge CMS to finalize rules to improve prior authorization

Today, the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) joined 61 bipartisan senators and 233 members of the House of Representatives in urging the U.S. Department of Health and Human Services and Centers for Medicare & Medicaid Services (CMS) to swiftly finalize rules to increase transparency, streamline and standardize prior authorization (PA).

4 Jul 2023

Technology News and Research

Bowel Research UK partners with Symplectic Grant Tracker to advance life-changing research

Researchers identify an enzyme that plays a critical role in the late stages of HIV replication

COST Connect: A platform for collaboration and progress in cancer research

Swarm learning shows promise in cancer research

Scientists develop breakthrough approach to create artificial allosteric sites in protein complexes

Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows

New therapy to mitigate fragile X syndrome may be on the horizon

Combination of techniques reveals molecular changes in osteoarthritis

Gum disease and tooth loss linked to brain shrinkage

New CRISPR-based system could eliminate malaria-carrying mosquitoes

TBI-associated depression may be a distinct disorder

Major agreement moves ground-breaking new cancer treatments a step closer to patients

Less than half of approved new drugs add substantial therapeutic value over existing treatments

Researchers develop dissolving cardiac device to monitor and treat heart disease

Using a vaccine to boost the response of engineered T cells

Arima Genomics continues momentum toward clinic with formation of clinical advisory board

Mount Sinai launches first-of-its-kind center for ophthalmic AI

Serious monkey business: Chimpanzee heart check via digital camera

Next step in Sartorius partnership finalized: Several subsales and distribution agreements as well as R&D project agreements have been signed

AANS, CNS urge CMS to finalize rules to improve prior authorization

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News